Comment on 'Sustained discontinuation of infliximab with a raising-dose strategy after obtaining remission in patients with rheumatoid arthritis: the RRRR study, a randomised controlled trial' by Tanaka et al

被引：3
|
作者：
Berkhout, Lea C. [1 ]
l'Ami, Merel J. [2 ]
Wolbink, Gerrit Jan [1 ,2 ]
Rispens, Theo [1 ]
机构：
[1] Sanquin Res, Immunopathol, Amsterdam, Netherlands
[2] Amsterdam Rheumatol & Immunol Ctr, Reade, Amsterdam, Netherlands
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2021年 / 80卷 / 11期
关键词：
anti-TNF; disease activity; rheumatoid arthritis; TNF-alpha; treatment;
D O I：
10.1136/annrheumdis-2019-216557
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：1
相关论文
共 42 条
  • [41] Adalimumab Added to a Treat-to-Target Strategy with Methotrexate and Intra-Articular Triamcinolone in Early Rheumatoid Arthritis Increased Remission Rates, Function and Quality of Life. The OPERA Study: An Investigator-Initiated, Randomised, Double-Blind, Parallel-Group, Placebo-Controlled Trial
    Lunzer, R.
    JOURNAL FUR MINERALSTOFFWECHSEL, 2013, 20 (03): : 116 - 117
  • [42] Adalimumab added to a treat-to-target strategy with methotrexate and intra-articular triamcinolone in early rheumatoid arthritis increased remission rates, function and quality of life. The OPERA Study: an investigator-initiated, randomised, double-blind, parallel-group, placebo-controlled trial
    Horslev-Petersen, Kim
    Hetland, Merete Lund
    Junker, Peter
    Podenphant, Jan
    Ellingsen, Torkell
    Ahlquist, Palle
    Lindegaard, Hanne
    Linauskas, Asta
    Schlemmer, Annette
    Dam, Mette Yde
    Hansen, Ib
    Horn, Hans Christian
    Ammitzboll, Christian Gytz
    Jorgensen, Anette
    Krintel, Sophine B.
    Raun, Johnny
    Johansen, Julia S.
    Ostergaard, Mikkel
    Stengaard-Pedersen, Kristian
    ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 (04) : 654 - 661
12345